Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_12105 | 21 | 0.43 | Mlig455_015631 | Neo: - Age: - |
Mlig455_015631 {REF} {Length: 1685} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=64.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=22.5]} {Smed: dd_Smed_v6_13742_0_1, dd_Smed_v6_13742_0_1, [Score=82.4, Expect=2e-17]} {RNA1310_95837} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.375 | 1.104 | 0.99955 | 1.00000 | |
RegionR2 | 5.565 | 1.104 | 0.01556 | 0.13201 | |
RegionR3 | 1.726 | 1.104 | 0.23399 | 0.77590 | |
RegionR4 | 2.059 | 1.104 | 0.14180 | 0.38535 | |
RegionR5 | -1.125 | 1.104 | 0.99972 | 1.00000 | |
RegionR6 | -0.439 | 1.104 | 0.99975 | 1.00000 | |
RegionR7 | -0.844 | 1.104 | 0.99977 | 1.00000 | |
RegionR8 | -1.567 | 1.104 | 0.99967 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 2.763 | 1.104 | 0.99992 | 1.00000 | |
RegenerationR2 | 0.995 | 1.104 | 0.49598 | 0.86978 | |
RegenerationR3 | 2.441 | 1.104 | 0.19085 | 0.62582 | |
RegenerationR4 | 0.6 | 1.104 | 0.55134 | 0.89329 | |
RegenerationR5 | 0.729 | 1.104 | 1.00000 | 1.00000 | |
RegenerationR6 | 2.579 | 1.104 | 0.23989 | 0.58761 | |
RegenerationBL | 0.69 | 1.104 | 0.99995 | 1.00000 | |
RegenerationTP | 1.019 | 1.104 | 0.99996 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_12105 | 21 | 0.43 | Mlig455_015631 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_015631 {REF} {Length: 1685} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=64.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=22.5]} {Smed: dd_Smed_v6_13742_0_1, dd_Smed_v6_13742_0_1, [Score=82.4, Expect=2e-17]} {RNA1310_95837} | |
2. | MligTC455_28055 | 19 | 0.41 | Mlig455_048300, Mlig455_048327, Mlig455_048344 | Neo: - Age: - |
MARK2, MARK4 | 2.852 | - | - | 0.993 | 0.926 | 0.933 | - | Mlig455_048300 {REF} {Length: 2504} {Pfam: Protein kinase domain [PF00069.27, score=157.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=86.8]; Kinase-like [PF14531.8, score=21.5]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=21.4]} {Human: ENSG00000007047, MARK4, microtubule affinity regulating kinase 4, [Score=158, Expect=1e-39]; ENSG00000072518, MARK2, microtubule affinity regulating kinase 2, [Score=157, Expect=2e-39]; ENSG00000075413, MARK3, microtubule affinity regulating kinase 3, [Score=152, Expect=7e-38]; ENSG00000160584, SIK3, SIK family kinase 3, [Score=152, Expect=2e-37]; ENSG00000074590, NUAK1, NUAK family kinase 1, [Score=151, Expect=1e-37]} {Mouse: ENSMUSG00000024969, Mark2, MAP/microtubule affinity regulating kinase 2, [Score=158, Expect=8e-40]; ENSMUSG00000030397, Mark4, MAP/microtubule affinity regulating kinase 4, [Score=156, Expect=3e-39]; ENSMUSG00000007411, Mark3, MAP/microtubule affinity regulating kinase 3, [Score=152, Expect=8e-38]; ENSMUSG00000009772, Nuak2, NUAK family, SNF1-like kinase, 2, [Score=151, Expect=7e-38]; ENSMUSG00000034135, Sik3, SIK family kinase 3, [Score=151, Expect=4e-37]; ENSMUSG00000020032, Nuak1, NUAK family, SNF1-like kinase, 1, [Score=151, Expect=1e-37]} {Dmel: FBgn0026064, KP78a, [Score=156, Expect=2e-39]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=163, Expect=4e-41]} {Smed: dd_Smed_v6_14823_0_1, dd_Smed_v6_14823_0_1, [Score=317, Expect=1e-97]} {RNA1310_58898} {RNA815_35373} Mlig455_048327 {REF} {Length: 2998} {Pfam: Protein kinase domain [PF00069.27, score=157.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=86.7]; Kinase-like [PF14531.8, score=21.4]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=21.3]} {Human: ENSG00000072518, MARK2, microtubule affinity regulating kinase 2, [Score=159, Expect=1e-39]; ENSG00000007047, MARK4, microtubule affinity regulating kinase 4, [Score=159, Expect=6e-40]; ENSG00000075413, MARK3, microtubule affinity regulating kinase 3, [Score=153, Expect=5e-38]; ENSG00000160584, SIK3, SIK family kinase 3, [Score=153, Expect=2e-37]; ENSG00000074590, NUAK1, NUAK family kinase 1, [Score=152, Expect=1e-37]} {Mouse: ENSMUSG00000024969, Mark2, MAP/microtubule affinity regulating kinase 2, [Score=159, Expect=7e-40]; ENSMUSG00000030397, Mark4, MAP/microtubule affinity regulating kinase 4, [Score=157, Expect=2e-39]; ENSMUSG00000009772, Nuak2, NUAK family, SNF1-like kinase, 2, [Score=152, Expect=5e-38]; ENSMUSG00000007411, Mark3, MAP/microtubule affinity regulating kinase 3, [Score=152, Expect=5e-38]; ENSMUSG00000034135, Sik3, SIK family kinase 3, [Score=152, Expect=3e-37]} {Dmel: FBgn0026064, KP78a, [Score=157, Expect=9e-40]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=164, Expect=2e-41]} {Smed: dd_Smed_v6_14823_0_1, dd_Smed_v6_14823_0_1, [Score=318, Expect=1e-97]} {RNA1310_58898} {RNA815_35373} Mlig455_048344 {REF} {Length: 2992} {Pfam: Protein kinase domain [PF00069.27, score=216.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=130.0]; Kinase-like [PF14531.8, score=22.0]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=21.6]} {Human: ENSG00000007047, MARK4, microtubule affinity regulating kinase 4, [Score=213, Expect=1e-58]; ENSG00000072518, MARK2, microtubule affinity regulating kinase 2, [Score=212, Expect=6e-58]; ENSG00000075413, MARK3, microtubule affinity regulating kinase 3, [Score=207, Expect=3e-56]; ENSG00000160584, SIK3, SIK family kinase 3, [Score=206, Expect=2e-54]} {Mouse: ENSMUSG00000024969, Mark2, MAP/microtubule affinity regulating kinase 2, [Score=212, Expect=3e-58]; ENSMUSG00000030397, Mark4, MAP/microtubule affinity regulating kinase 4, [Score=212, Expect=5e-58]; ENSMUSG00000034135, Sik3, SIK family kinase 3, [Score=207, Expect=3e-55]; ENSMUSG00000007411, Mark3, MAP/microtubule affinity regulating kinase 3, [Score=206, Expect=4e-56]} {Dmel: FBgn0026064, KP78a, [Score=213, Expect=1e-58]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=217, Expect=7e-59]} {Smed: dd_Smed_v6_14823_0_1, dd_Smed_v6_14823_0_1, [RH, Score=465, Expect=5e-154]} {RNA1310_58898} {RNA815_35373} |
3. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 2.721 | - | - | 0.793 | 0.945 | 0.983 | - | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
4. | MligTC455_40011 | 150 | 3.12 | Mlig455_004436, Mlig455_004448 | Neo: - |
2.702 | - | - | 0.802 | 0.916 | 0.984 | - | Mlig455_004436 {REF} {Length: 595} {RNA1310_81676} Mlig455_004448 {REF} {Length: 1192} {RNA1310_81676} |
|
5. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 2.653 | - | 0.813 | - | 0.951 | 0.889 | - | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
6. | MligTC455_17187 | 85 | 1.77 | Mlig455_040722 | Neo: - Age: logFC(26M/2M)=-0.644 |
SCNN1B | 2.619 | - | - | 0.719 | 0.917 | 0.983 | - | Mlig455_040722 {REF} {Length: 2368} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.4]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=64.3, Expect=5e-10]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_25838_0_1, dd_Smed_v6_25838_0_1, [Score=230, Expect=3e-67]} {RNA1509_57515} {RNA1310_24808, RNA1509_57515} {RNA1509_57515, RNA815_46525} |
7. | MligTC455_44972 | 344 | 7.16 | Mlig455_020200 | Neo: - Age: - |
CEP72 | 2.47 | - | - | 0.721 | 0.795 | 0.954 | - | Mlig455_020200 {REF} {Length: 3284} {Pfam: Leucine-rich repeat [PF14580.8, score=42.1]} {Human: ENSG00000112877, CEP72, centrosomal protein 72, [RH, Score=149, Expect=4e-37]; ENSG00000280688, CEP72, centrosomal protein 72, [RH, Score=143, Expect=3e-39]} {Mouse: ENSMUSG00000021572, Cep72, centrosomal protein 72, [RH, Score=153, Expect=1e-38]} {Smed: dd_Smed_v6_12835_0_1, dd_Smed_v6_12835_0_1, [RH, Score=174, Expect=3e-47]} {RNA1509_31408} {RNA1310_4875, RNA1509_31408} {RNA1509_31408, RNA815_15532} |
8. | MligTC455_10293 | 24 | 0.5 | Mlig455_034227 | Neo: Germline Age: - Region-enriched R4: 3.468/0.02745 |
1.955 | 0.988 | - | - | - | - | 0.967 | Mlig455_034227 {REF} {Length: 1019} {Pfam: LITAF-like zinc ribbon domain [PF10601.11, score=47.4]} {RNA1509_57780} {RNA1310_66882} {RNA815_29775} | |
9. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
1.953 | - | - | - | 0.975 | 0.978 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
10. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 1.952 | - | - | - | 0.988 | 0.964 | - | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
11. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 1.945 | - | - | - | 0.965 | 0.980 | - | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
12. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
1.941 | - | - | - | 0.984 | 0.957 | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
13. | MligTC455_37989 | 83 | 1.72 | Mlig455_018192 | Neo: - Age: - |
1.941 | - | - | - | 0.942 | 0.999 | - | Mlig455_018192 {REF} {Length: 1275} {Pfam: EF-hand domain pair [PF13499.8, score=36.8]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.5]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=105, Expect=6e-27]} {RNA1310_31713.1} {RNA815_36423} | |
14. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 1.932 | - | - | - | 0.968 | 0.964 | - | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
15. | MligTC455_42841 | 550 | 11.45 | Mlig455_019999 | Neo: - Age: logFC(26M/2M)=-0.374 Region-specific R2: 6.903 Region-enriched R2: 6.896/0.00000 |
DDC | 1.926 | - | - | - | 0.951 | 0.975 | - | Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1} |
16. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 1.921 | - | - | - | 0.959 | 0.962 | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
17. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 1.917 | - | - | - | 0.967 | 0.950 | - | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
18. | MligTC455_48760 | 15 | 0.31 | Mlig455_009006 | Neo: - Age: - |
SULT1A1 | 1.915 | - | - | - | 0.979 | 0.936 | - | Mlig455_009006 {REF} {Length: 1306} {Pfam: Sulfotransferase domain [PF00685.29, score=204.1]; Sulfotransferase family [PF13469.8, score=33.6]} {Human: ENSG00000196502, SULT1A1, sulfotransferase family 1A member 1, [RH, Score=162, Expect=4e-47]} {Mouse: ENSMUSG00000029269, Sult1b1, sulfotransferase family 1B, member 1, [RH, Score=167, Expect=8e-49]} {Dmel: FBgn0037665, St2, Sulfotransferase 2, [Score=131, Expect=4e-35]} {Celegans: WBGene00013748, ssu-1, Suppressor of Stomatin mutant Uncoordination, [Score=108, Expect=2e-26]} {Smed: dd_Smed_v6_34919_0_1, dd_Smed_v6_34919_0_1, [RH, Score=276, Expect=2e-91]} {RNA1310_95833} |
19. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
1.914 | - | - | - | 0.965 | 0.949 | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
20. | MligTC455_18583 | 12 | 0.24 | Mlig455_045246 | Neo: - Age: - |
1.912 | - | - | - | 0.984 | 0.928 | - | Mlig455_045246 {REF} {Length: 719} | |
21. | MligTC455_46285 | 568 | 11.84 | Mlig455_063390 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 4.933/0.00026 |
1.911 | - | - | - | 0.970 | 0.941 | - | Mlig455_063390 {REF} {Length: 871} {RNA1509_48573} {RNA1310_59611, RNA1509_48573} {RNA1509_48573, RNA815_35731} | |
22. | MligTC455_20114 | 4655 | 96.97 | Mlig455_032750 | Neo: - Age: - Region-enriched R2: 6.812/0.00000 |
ADAMTS7 | 1.91 | - | - | - | 0.946 | 0.964 | - | Mlig455_032750 {REF} {Length: 1794} {Pfam: Metallo-peptidase family M12 [PF13688.8, score=51.5]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=44.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=39.8]; Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=37.0]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=26.8]; ADAM cysteine-rich domain [PF17771.3, score=26.3]; Astacin (Peptidase family M12A) [PF01400.26, score=18.3]} {Human: ENSG00000136378, ADAMTS7, ADAM metallopeptidase with thrombospondin type 1 motif 7, [Score=72.4, Expect=1e-12]; ENSG00000134917, ADAMTS8, ADAM metallopeptidase with thrombospondin type 1 motif 8, [Score=72.0, Expect=1e-12]} {Mouse: ENSMUSG00000058145, Adamts17, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17, [Score=70.5, Expect=3e-12]; ENSMUSG00000031994, Adamts8, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8, [Score=70.1, Expect=3e-12]; ENSMUSG00000046169, Adamts6, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6, [Score=69.7, Expect=4e-12]; ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=68.2, Expect=1e-11]; ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=67.4, Expect=2e-11]} {Dmel: FBgn0029791, CG4096, [Score=74.3, Expect=1e-13]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [Score=58.5, Expect=6e-09]} {RNA1509_811} {RNA1310_18102.1, RNA1509_811} {RNA1509_811, RNA815_7066} |
23. | MligTC455_20113 | 4626 | 96.37 | Mlig455_032728 | Neo: - Age: - Region-enriched R2: 7.104/0.00000 |
ADAMTS4 | 1.909 | - | - | - | 0.945 | 0.964 | - | Mlig455_032728 {REF} {Length: 1834} {Pfam: Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=34.1]; Metallo-peptidase family M12 [PF13688.8, score=30.1]} {Human: ENSG00000158859, ADAMTS4, ADAM metallopeptidase with thrombospondin type 1 motif 4, [Score=50.1, Expect=3e-06]; ENSG00000154734, ADAMTS1, ADAM metallopeptidase with thrombospondin type 1 motif 1, [Score=48.1, Expect=3e-06]} {Mouse: ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=50.1, Expect=2e-06]} {RNA1509_811} {RNA1310_18102.1} {RNA815_7066} |
24. | MligTC455_16866 | 18 | 0.37 | Mlig455_065296 | Neo: - Age: - |
1.907 | - | - | - | 0.957 | 0.950 | - | Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472} | |
25. | MligTC455_16867 | 18 | 0.37 | Mlig455_065319 | Neo: - Age: - |
1.907 | - | - | - | 0.957 | 0.950 | - | Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472} | |
26. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
1.907 | - | - | - | 0.968 | 0.939 | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
27. | MligTC455_45080 | 3677 | 76.61 | Mlig455_021478, Mlig455_062024, Mlig455_063226, Mlig455_067363 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.291 Region-enriched R8: 1.930/0.00003 |
1.902 | - | - | - | 0.934 | 0.968 | - | Mlig455_021478 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_062024 {REF} {Length: 752} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_063226 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_067363 {REF} {Length: 767} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} |
|
28. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
1.902 | - | - | - | 0.988 | 0.914 | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
29. | MligTC455_12085 | 11 | 0.22 | Mlig455_058618 | Neo: - Age: - |
NPFFR2 | 1.902 | - | - | - | 0.950 | 0.952 | - | Mlig455_058618 {REF} {Length: 1772} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=137.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.1]; Olfactory receptor [PF13853.8, score=20.7]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=6e-32]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=127, Expect=5e-32]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=169, Expect=1e-46]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=163, Expect=2e-45]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=248, Expect=3e-77]} |
30. | MligTC455_47741 | 102 | 2.13 | Mlig455_004211 | Neo: - Age: Down-Up-Up |
1.899 | - | - | - | 0.935 | 0.964 | - | Mlig455_004211 {REF} {Length: 1794} {RNA1310_23101} {RNA815_45601} | |
31. | MligTC455_03892 | 8 | 0.18 | Mlig455_009194 | Neo: - Age: - |
1.898 | - | - | 0.997 | - | 0.901 | - | Mlig455_009194 {REF} {Length: 2218} {TRANSSPLICED} {Dmel: FBgn0035248, CG13919, [RH, Score=45.4, Expect=1e-05]} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=255, Expect=7e-81]} {RNA1509_28905} {RNA1310_72348.1} {RNA815_44982} | |
32. | MligTC455_23100 | 527 | 10.99 | Mlig455_019660 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.306 Region-enriched R2: 3.360/0.00019 |
1.897 | - | - | - | 0.962 | 0.935 | - | Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585} | |
33. | MligTC455_02622 | 18 | 0.38 | Mlig455_034646, Mlig455_062629 | Neo: - Age: - |
CACNG5 | 1.894 | - | - | - | 0.928 | 0.966 | - | Mlig455_034646 {REF} {Length: 1447} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=49.4]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=36.5]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=73.2, Expect=3e-14]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=72.4, Expect=4e-14]} {RNA1310_115007} {RNA815_41269} Mlig455_062629 {REF} {Length: 1628} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=49.4]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=36.5]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=73.2, Expect=3e-14]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=72.4, Expect=4e-14]} {RNA1310_115007} {RNA815_41269} |
34. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.887 | - | - | - | 0.958 | 0.929 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
35. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
1.886 | - | - | - | 0.928 | 0.958 | - | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
36. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 1.885 | - | - | - | 0.977 | 0.908 | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
37. | MligTC455_50255 | 777 | 16.18 | Mlig455_018293 | Neo: - Age: Down-Up-Up Region-enriched R2: 1.926/0.01583 |
1.884 | - | - | - | 0.917 | 0.967 | - | Mlig455_018293 {REF} {Length: 691} {Smed: dd_Smed_v6_8966_0_1, dd_Smed_v6_8966_0_1, [RH, Score=70.9, Expect=1e-16]} {RNA1509_37352} {RNA1310_62086} {RNA815_22267.2} | |
38. | MligTC455_50177 | 26 | 0.55 | Mlig455_050182 | Neo: - Age: - |
1.883 | - | - | 0.985 | - | 0.898 | - | Mlig455_050182 {REF} {Length: 1326} {RNA1310_32436} | |
39. | MligTC455_43389 | 18 | 0.38 | Mlig455_019091 | Neo: - Age: - |
PRKAR2A | 1.879 | - | - | - | 0.959 | 0.920 | - | Mlig455_019091 {REF} {Length: 2410} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.4]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=297, Expect=5e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=297, Expect=5e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=313, Expect=9e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=6e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
40. | MligTC455_17039 | 24 | 0.5 | Mlig455_025016 | Neo: - Age: - |
1.871 | - | - | - | 0.911 | 0.960 | - | Mlig455_025016 {REF} {Length: 2009} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.8]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [RH, Score=209, Expect=1e-63]} {RNA1310_42205} {RNA815_15017} | |
41. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 1.871 | - | - | - | 0.896 | 0.975 | - | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
42. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
1.868 | - | - | - | 0.874 | 0.994 | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
43. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 1.866 | - | - | - | 0.889 | 0.977 | - | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
44. | MligTC455_25880 | 81 | 1.7 | Mlig455_005910 | Neo: - Age: logFC(26M/2M)=-0.680 |
PRR9 | 1.865 | - | - | - | 0.910 | 0.955 | - | Mlig455_005910 {REF} {Length: 2049} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=45.8, Expect=7e-06]} {RNA1509_54214} {RNA1310_38311.2} {RNA815_8809.1} |
45. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 1.865 | - | - | - | 0.969 | 0.896 | - | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
46. | MligTC455_03895 | 18 | 0.37 | Mlig455_009197, Mlig455_009619 | Neo: - Age: Down-Up-Down |
1.864 | - | - | 0.982 | - | 0.882 | - | Mlig455_009197 {REF} {Length: 1774} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [Score=254, Expect=7e-82]} {RNA1310_72348.1} {RNA815_44982} Mlig455_009619 {REF} {Length: 1794} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [Score=254, Expect=7e-82]} {RNA1310_72348.1} {RNA815_44982} |
|
47. | MligTC455_40649 | 24 | 0.49 | Mlig455_066232 | Neo: - Age: - |
1.863 | - | - | - | 0.898 | 0.965 | - | Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590} | |
48. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
1.86 | - | - | - | 0.897 | 0.963 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
49. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
1.858 | - | - | - | 0.871 | 0.987 | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
50. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 1.857 | - | - | - | 0.962 | 0.895 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
51. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
1.856 | - | - | - | 0.882 | 0.974 | - | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
52. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
1.855 | - | - | - | 0.951 | 0.904 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
53. | MligTC455_15996 | 396 | 8.26 | Mlig455_064976, Mlig455_066809 | Neo: - Age: - |
ARHGEF17 | 1.855 | - | - | - | 0.886 | 0.969 | - | Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497} Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184} |
54. | MligTC455_48720 | 1367 | 28.48 | Mlig455_017034 | Neo: - Age: - Region-specific R2: 4.593 Region-enriched R2: 3.164/0.00157 |
1.855 | - | - | - | 0.954 | 0.901 | - | Mlig455_017034 {REF} {Length: 866} {RNA1509_17554, RNA1509_28146} {RNA1310_40772, RNA1509_28146} {RNA1509_28146, RNA815_29897} | |
55. | MligTC455_48523 | 615 | 12.81 | Mlig455_027573 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.661 Region-enriched R2: 5.785/0.00008 |
1.853 | - | - | - | 0.875 | 0.978 | - | Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574} | |
56. | MligTC455_07747 | 55 | 1.14 | Mlig455_016698 | Neo: - Age: - |
1.852 | 0.855 | - | - | - | - | 0.997 | Mlig455_016698 {REF} {Length: 774} {RNA1310_51880} {RNA815_35003} | |
57. | MligTC455_15694 | 54 | 1.13 | Mlig455_026426, Mlig455_026456 | Neo: - Age: - Region-enriched R2: 6.151/0.00957 |
SSTR1 | 1.852 | - | - | - | - | 0.966 | 0.886 | Mlig455_026426 {REF} {Length: 2191} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.7]; Olfactory receptor [PF13853.8, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=6e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=4e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=5e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=2e-33]} {RNA1310_38996} {RNA815_25059} Mlig455_026456 {REF} {Length: 2423} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=26.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=5e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=3e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=7e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=110, Expect=2e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=1e-33]} {RNA1310_38996} {RNA815_25059} |
58. | MligTC455_46775 | 3655 | 76.14 | Mlig455_034423 | Neo: - Age: - Region-enriched R2: 6.976/0.00000 |
CAV1 | 1.85 | - | - | - | 0.896 | 0.954 | - | Mlig455_034423 {REF} {Length: 1041} {Pfam: Caveolin [PF01146.19, score=114.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=94.7, Expect=4e-25]; ENSG00000182533, CAV3, caveolin 3, [Score=92.4, Expect=3e-24]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=92.4, Expect=2e-24]; ENSMUSG00000062694, Cav3, caveolin 3, [Score=91.3, Expect=6e-24]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=70.9, Expect=1e-15]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [Score=130, Expect=1e-39]} {RNA1509_5585, RNA1509_8418} {RNA1310_21291.2, RNA1509_5585, RNA1509_8418} {RNA1509_5585, RNA1509_8418, RNA815_11992} |
59. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
1.85 | - | - | - | 0.883 | 0.967 | - | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
60. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
1.841 | - | - | - | 0.844 | 0.997 | - | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} | |
61. | MligTC455_40559 | 119 | 2.48 | Mlig455_063539 | Neo: - Age: - |
FO681492.1 | 1.84 | - | - | - | 0.888 | 0.952 | - | Mlig455_063539 {REF} {Length: 2231} {Pfam: C2 domain [PF00168.32, score=40.3]} {Human: ENSG00000277758, FO681492.1, synaptotagmin-15, [Score=74.3, Expect=1e-13]; ENSG00000204176, SYT15, synaptotagmin 15, [Score=73.9, Expect=1e-13]} {Mouse: ENSMUSG00000041479, Syt15, synaptotagmin XV, [Score=65.5, Expect=6e-11]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=52.4, Expect=4e-07]} {RNA1310_23463.1} {RNA815_43860} |
62. | MligTC455_46009 | 5464 | 113.82 | Mlig455_061251, Mlig455_062639 | Neo: - Age: logFC(26M/2M)=-0.276 Region-specific R2: 2.871 Region-enriched R2: 2.103/0.00001 |
1.84 | - | - | - | 0.955 | 0.885 | - | Mlig455_061251 {REF} {Length: 1343} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} Mlig455_062639 {REF} {Length: 1176} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} |
|
63. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
1.839 | - | - | - | 0.878 | 0.961 | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
64. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 1.838 | - | - | - | 0.984 | 0.854 | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
65. | MligTC455_53827 | 41 | 0.85 | Mlig455_057728 | Neo: - Age: - Region-enriched R2: 6.363/0.00033 |
1.833 | - | 0.873 | - | - | 0.960 | - | Mlig455_057728 {REF} {Length: 1074} {RNA1310_41119} {RNA815_15825} | |
66. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
1.832 | - | - | - | 0.878 | 0.954 | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
67. | MligTC455_52727 | 82 | 1.72 | Mlig455_043336 | Neo: - Age: Down-Up-Down |
1.832 | - | - | - | 0.958 | 0.874 | - | Mlig455_043336 {REF} {Length: 1410} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=60.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=20.9]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=131, Expect=4e-35]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
68. | MligTC455_22125 | 178 | 3.71 | Mlig455_028579, Mlig455_028597 | Neo: - Age: - Region-enriched R2: 5.949/0.00261 |
1.827 | - | - | - | 0.973 | 0.854 | - | Mlig455_028579 {REF} {Length: 993} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} Mlig455_028597 {REF} {Length: 962} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} |
|
69. | MligTC455_50363 | 942 | 19.62 | Mlig455_012474 | Neo: - Age: Down-Up-Up Region-specific R2: 4.264 Region-enriched R2: 3.827/0.00000 |
1.827 | - | - | - | 0.846 | 0.981 | - | Mlig455_012474 {REF} {Length: 886} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
70. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 1.826 | - | - | - | 0.847 | 0.979 | - | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
71. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
1.824 | - | - | - | 0.984 | 0.840 | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
72. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
1.823 | - | - | - | 0.981 | 0.842 | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
73. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 1.821 | - | - | - | 0.964 | 0.857 | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
74. | MligTC455_42493 | 77 | 1.6 | Mlig455_033955 | Neo: - Age: - |
1.82 | - | - | - | 0.861 | 0.959 | - | Mlig455_033955 {REF} {Length: 878} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=75.9, Expect=3e-16]} {RNA1310_57572} | |
75. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1.818 | - | - | - | 0.952 | 0.866 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
76. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 1.816 | - | - | - | 0.961 | 0.855 | - | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
77. | MligTC455_02495 | 2759 | 57.47 | Mlig455_039292 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.530/0.00442 |
1.813 | - | - | 0.842 | 0.971 | - | - | Mlig455_039292 {REF} {Length: 910} {RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1310_15694.2, RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1509_35923, RNA1509_4995, RNA1509_7740, RNA815_5222} | |
78. | MligTC455_32903 | 29 | 0.6 | Mlig455_037926 | Neo: - Age: - |
1.813 | - | - | - | 0.838 | 0.975 | - | Mlig455_037926 {REF} {Length: 1892} {RNA1310_57340} {RNA815_53132} | |
79. | MligTC455_52003 | 1043 | 21.73 | Mlig455_050564, Mlig455_050571 | Neo: - Age: - |
RGS4, RGS8 | 1.813 | - | - | - | 0.838 | 0.975 | - | Mlig455_050564 {REF} {Length: 3240} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=116.7]} {Human: ENSG00000117152, RGS4, regulator of G protein signaling 4, [RH, Score=149, Expect=2e-42]} {Mouse: ENSMUSG00000038530, Rgs4, regulator of G-protein signaling 4, [RH, Score=153, Expect=4e-44]; ENSMUSG00000026678, Rgs5, regulator of G-protein signaling 5, [RH, Score=149, Expect=1e-42]; ENSMUSG00000042671, Rgs8, regulator of G-protein signaling 8, [RH, Score=149, Expect=1e-42]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=118, Expect=2e-30]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_8648_0_1, dd_Smed_v6_8648_0_1, [RH, Score=199, Expect=4e-58]} {RNA1509_11015, RNA1509_27306} {RNA1310_4876, RNA1509_11015, RNA1509_27306} {RNA1509_11015, RNA1509_27306, RNA815_6054} Mlig455_050571 {REF} {Length: 2222} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=118.3]} {Human: ENSG00000135824, RGS8, regulator of G protein signaling 8, [RH, Score=149, Expect=9e-45]; ENSG00000117152, RGS4, regulator of G protein signaling 4, [RH, Score=149, Expect=2e-44]; ENSG00000150681, RGS18, regulator of G protein signaling 18, [RH, Score=146, Expect=5e-43]; ENSG00000143248, RGS5, regulator of G protein signaling 5, [RH, Score=144, Expect=7e-43]} {Mouse: ENSMUSG00000038530, Rgs4, regulator of G-protein signaling 4, [RH, Score=153, Expect=5e-46]; ENSMUSG00000042671, Rgs8, regulator of G-protein signaling 8, [RH, Score=151, Expect=1e-45]; ENSMUSG00000026678, Rgs5, regulator of G-protein signaling 5, [RH, Score=147, Expect=7e-44]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=117, Expect=1e-31]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [Score=124, Expect=7e-35]} {Smed: dd_Smed_v6_8648_0_1, dd_Smed_v6_8648_0_1, [RH, Score=192, Expect=1e-57]} {RNA1509_27306} {RNA1310_5436.1} {RNA815_6054} |
80. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
1.811 | - | - | - | 0.961 | 0.850 | - | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
81. | MligTC455_31625 | 130 | 2.7 | Mlig455_069168 | Neo: - Age: Up-Down-Up |
1.808 | - | - | 0.966 | 0.842 | - | - | Mlig455_069168 {REF} {Length: 4740} {RNA1509_55535} {RNA1310_35152.1} {RNA815_5895} | |
82. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 1.807 | - | - | - | 0.983 | 0.824 | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
83. | MligTC455_23825 | 29 | 0.6 | Mlig455_002166, Mlig455_002310 | Neo: - Age: Down-Up-Down |
NOL4 | 1.807 | - | - | - | 0.964 | 0.843 | - | Mlig455_002166 {REF} {Length: 3243} {Human: ENSG00000101746, NOL4, nucleolar protein 4, [RH, Score=135, Expect=9e-35]} {Mouse: ENSMUSG00000041923, Nol4, nucleolar protein 4, [RH, Score=136, Expect=1e-34]} {Dmel: FBgn0283651, CG46301, [RH, Score=140, Expect=4e-35]} {Smed: dd_Smed_v6_10255_0_1, dd_Smed_v6_10255_0_1, [RH, Score=82.4, Expect=6e-17]} {RNA1509_41791} {RNA1310_36173.1} {RNA815_37287} Mlig455_002310 {REF} {Length: 2667} {Human: ENSG00000101746, NOL4, nucleolar protein 4, [RH, Score=135, Expect=1e-34]} {Mouse: ENSMUSG00000041923, Nol4, nucleolar protein 4, [RH, Score=136, Expect=1e-34]} {Dmel: FBgn0283651, CG46301, [RH, Score=140, Expect=4e-35]} {Smed: dd_Smed_v6_10255_0_1, dd_Smed_v6_10255_0_1, [RH, Score=82.4, Expect=6e-17]} {RNA1509_41791} {RNA1310_36173.1} |
84. | MligTC455_23099 | 185 | 3.85 | Mlig455_048061 | Neo: - |
1.806 | - | - | - | 0.853 | 0.953 | - | Mlig455_048061 {REF} {Length: 713} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452} {RNA815_4585} | |
85. | MligTC455_49617 | 561 | 11.69 | Mlig455_053826, Mlig455_068519 | Neo: - Age: - Region-enriched R2: 2.210/0.00459 |
CPNE8, CPNE9 | 1.806 | - | - | - | 0.849 | 0.957 | - | Mlig455_053826 {REF} {Length: 3677} {Pfam: Copine [PF07002.18, score=235.6]; Pentapeptide repeats (8 copies) [PF00805.24, score=224.2]; Pentapeptide repeats (9 copies) [PF13576.8, score=203.8]; Pentapeptide repeats (9 copies) [PF13599.8, score=185.9]; C2 domain [PF00168.32, score=40.3]; vWA found in TerF C terminus [PF10138.11, score=20.7]} {Human: ENSG00000139117, CPNE8, copine 8, [Score=301, Expect=2e-90]; ENSG00000144550, CPNE9, copine family member 9, [Score=300, Expect=4e-90]; ENSG00000124772, CPNE5, copine 5, [Score=295, Expect=2e-87]; ENSG00000214078, CPNE1, copine 1, [Score=289, Expect=3e-86]} {Mouse: ENSMUSG00000052560, Cpne8, copine VIII, [Score=302, Expect=9e-91]; ENSMUSG00000030270, Cpne9, copine family member IX, [Score=300, Expect=2e-90]; ENSMUSG00000024008, Cpne5, copine V, [Score=294, Expect=2e-87]} {Celegans: WBGene00001577, gem-4, Gon-2 Extragenic Modifier, [Score=216, Expect=8e-60]} {Smed: dd_Smed_v6_13873_0_1, dd_Smed_v6_13873_0_1, [Score=392, Expect=3e-124]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_4873} Mlig455_068519 {REF} {Length: 2381} {Pfam: Copine [PF07002.18, score=237.0]; C2 domain [PF00168.32, score=50.8]; vWA found in TerF C terminus [PF10138.11, score=22.6]} {Human: ENSG00000144550, CPNE9, copine family member 9, [Score=407, Expect=2e-135]; ENSG00000139117, CPNE8, copine 8, [Score=398, Expect=9e-132]} {Mouse: ENSMUSG00000030270, Cpne9, copine family member IX, [Score=409, Expect=2e-136]; ENSMUSG00000052560, Cpne8, copine VIII, [Score=400, Expect=2e-132]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=294, Expect=3e-91]} {Smed: dd_Smed_v6_13873_0_1, dd_Smed_v6_13873_0_1, [RH, Score=566, Expect=0.0]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_4873} |
86. | MligTC455_31675 | 71 | 1.49 | Mlig455_001806, Mlig455_062232 | Neo: - Age: - |
1.805 | 0.850 | - | - | - | - | 0.955 | Mlig455_001806 {REF} {Length: 1760} {Pfam: Syntaxin 6, N-terminal [PF09177.13, score=32.9]} {RNA1509_55597} {RNA1310_30832} {RNA815_15518} Mlig455_062232 {REF} {Length: 1371} {Pfam: Poly(ADP-ribose) polymerase catalytic domain [PF00644.22, score=58.4]} {RNA1509_55597} {RNA1310_35578} {RNA815_15518} |
|
87. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
1.802 | - | - | - | 0.969 | 0.833 | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
88. | MligTC455_42784 | 842 | 17.55 | Mlig455_004621, Mlig455_004630, Mlig455_004657 | Neo: - Age: - Region-enriched R2: 2.895/0.00752 |
1.8 | - | - | - | 0.838 | 0.962 | - | Mlig455_004621 {REF} {Length: 1246} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} Mlig455_004630 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.2} {RNA815_16689.1} Mlig455_004657 {REF} {Length: 1250} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} |
|
89. | MligTC455_54106 | 87 | 1.81 | Mlig455_046338, Mlig455_068234 | Neo: Int S/G2/M Age: Up-Down-Down |
PLCB1, PLCB3 | 1.795 | - | - | - | 0.954 | 0.841 | - | Mlig455_046338 {REF} {Length: 4577} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.8]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=69.3]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.5]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [Score=797, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [Score=796, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [Score=801, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=418, Expect=4e-125]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=671, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=702, Expect=0.0]} {RNA1509_50989} {RNA1310_17477} {RNA815_25811} Mlig455_068234 {REF} {Length: 4646} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=123.2]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=837, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=831, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=830, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=827, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=444, Expect=7e-134]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=684, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=716, Expect=0.0]} {RNA1509_50989} {RNA1310_17477, RNA1509_50989} {RNA1509_50989, RNA815_25811} |
90. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
1.794 | - | - | - | 0.956 | 0.838 | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
91. | MligTC455_17947 | 64 | 1.34 | Mlig455_042563 | Neo: - Age: - Region-enriched R2: 7.054/0.00113 |
ASCL5 | 1.793 | - | - | - | 0.810 | 0.983 | - | Mlig455_042563 {REF} {Length: 1821} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=52.5]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=84.7, Expect=6e-20]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=84.0, Expect=5e-20]} {Dmel: FBgn0002922, nau, nautilus, [Score=49.3, Expect=6e-07]} {Celegans: WBGene00001952, hlh-6, Helix-loop-helix protein 6, [RH, Score=90.9, Expect=4e-22]} {Smed: dd_Smed_v6_14753_0_1, dd_Smed_v6_14753_0_1, [RH, Score=76.6, Expect=2e-17]} {RNA1310_71187} |
92. | MligTC455_29317 | 89 | 1.85 | Mlig455_062533 | Neo: - Age: logFC(26M/2M)=0.866 |
SLC18A3 | 1.793 | - | - | - | 0.820 | 0.973 | - | Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951} |
93. | MligTC455_14039 | 24 | 0.5 | Mlig455_045412 | Neo: - Age: - |
ANGPTL3 | 1.791 | - | - | - | 0.830 | 0.961 | - | Mlig455_045412 {REF} {Length: 1491} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=55.0]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=48.9, Expect=1e-05]} {Dmel: FBgn0031804, CG9500, [Score=63.9, Expect=3e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=58.2, Expect=4e-09]} {RNA1509_53291} {RNA1310_91324} {RNA815_10579.1} |
94. | MligTC455_51271 | 681 | 14.19 | Mlig455_021899, Mlig455_021976, Mlig455_022029 | Neo: - Age: - Region-specific R2: 6.767 Region-enriched R2: 4.145/0.01904 |
FOXA2 | 1.791 | - | - | - | 0.815 | 0.976 | - | Mlig455_021899 {REF} {Length: 3015} {Pfam: Forkhead domain [PF00250.20, score=129.1]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=224, Expect=1e-66]; ENSG00000129514, FOXA1, forkhead box A1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=228, Expect=3e-68]} {Dmel: FBgn0000659, fkh, fork head, [Score=233, Expect=8e-70]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=197, Expect=9e-58]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=239, Expect=1e-72]} {RNA1509_29593, RNA1509_56864} {RNA1310_6263, RNA1509_29593, RNA1509_56864} {RNA1509_29593, RNA1509_56864, RNA815_8556} Mlig455_021976 {REF} {Length: 2892} {Pfam: Forkhead domain [PF00250.20, score=129.2]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=222, Expect=2e-66]; ENSG00000129514, FOXA1, forkhead box A1, [Score=214, Expect=3e-63]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=226, Expect=4e-68]} {Dmel: FBgn0000659, fkh, fork head, [Score=231, Expect=1e-69]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=238, Expect=1e-72]} {RNA1509_29593} {RNA1310_6263} {RNA815_8556} Mlig455_022029 {REF} {Length: 3066} {Pfam: Forkhead domain [PF00250.20, score=31.9]} {Human: ENSG00000125798, FOXA2, forkhead box A2, [Score=80.9, Expect=5e-17]; ENSG00000129514, FOXA1, forkhead box A1, [Score=80.1, Expect=7e-17]} {Mouse: ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=83.6, Expect=4e-18]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=80.1, Expect=3e-17]; ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=79.7, Expect=6e-17]} {Dmel: FBgn0000659, fkh, fork head, [Score=89.0, Expect=3e-20]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=72.8, Expect=9e-15]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=103, Expect=1e-25]} {RNA1509_29593} {RNA1310_6263} {RNA815_8556} |
95. | MligTC455_21668 | 84 | 1.74 | Mlig455_024837 | Neo: - |
PPP3R1 | 1.79 | - | - | - | 0.950 | 0.840 | - | Mlig455_024837 {REF} {Length: 1650} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613} {RNA1310_16848.1} {RNA815_6272} |
96. | MligTC455_21182 | 238 | 4.96 | Mlig455_000068, Mlig455_063733 | Neo: - Age: Down-Up-Up Region-enriched R4: 5.301/0.04587 |
1.786 | - | - | - | 0.968 | 0.818 | - | Mlig455_000068 {REF} {Length: 468} {Pfam: Pancreatic hormone peptide [PF00159.20, score=23.7]} {RNA1310_81800.1} {RNA815_55075} Mlig455_063733 {REF} {Length: 531} {Pfam: Pancreatic hormone peptide [PF00159.20, score=20.7]} {RNA1310_81800.1} {RNA815_55075} |
|
97. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 1.786 | - | - | - | 0.822 | 0.964 | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
98. | MligTC455_18227 | 82 | 1.71 | Mlig455_014781 | Neo: - Age: - |
1.784 | - | - | - | 0.831 | 0.953 | - | Mlig455_014781 {REF} {Length: 4541} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=26.2]; Mab-21 protein [PF03281.16, score=25.9]} {RNA1509_35479} {RNA1310_2311.1} {RNA815_13099} | |
99. | MligTC455_02494 | 237 | 4.93 | Mlig455_004106 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.703/0.00228 |
1.783 | - | - | 0.812 | 0.971 | - | - | Mlig455_004106 {REF} {Length: 917} {RNA1509_21522, RNA1509_4995} {RNA1310_15694.2, RNA1509_21522} {RNA1509_21522, RNA815_5222} | |
100. | MligTC455_24345 | 161 | 3.36 | Mlig455_001456 | Neo: - Age: - |
1.782 | - | - | - | 0.820 | 0.962 | - | Mlig455_001456 {REF} {Length: 3298} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.3]} {RNA1310_23364} {RNA815_42991} |